Bariatric and Obstructive Lung Disease Study II
This trial is active, not recruiting.
|Sponsor||Johns Hopkins University|
|Collaborator||National Heart, Lung, and Blood Institute (NHLBI)|
|Start date||September 2009|
|End date||July 2012|
|Trial size||120 participants|
|Trial identifier||NCT01127399, K23HL097081, NA_00027264|
The prevalence of obesity and asthma has significantly increased over the past two decades. The purpose of this study is to try and understand the mechanism by which obesity leads to airway hyperresponsiveness (AHR), one of the defining features of asthma. This research is being done to determine how weight or body size affects airway size and airway smooth muscle (ASM) tone and function. The goal of the study will be to look at if and how, weight might affect lung functioning.
The investigators hypothesize that low lung volumes in obesity lead to AHR by reducing airway caliber causing increased ASM tone with impairment in deep inspiration (DI) response similar to what is seen in asthma.
Male or female participants at least 18 years old.
- Age 18 years or older
- BMI over 35 kg/m2 (Bariatric) or BMI between 25 and 28 kg/m2 (Control)
- Physician diagnosis of asthma and on active asthma medication (if asthmatic)
- Weight greater than 450 lbs
- Unstable cardiovascular disease
- Uncontrolled hypertension
- Renal failure on dialysis
- Pregnant or lactating
- Bleeding disorders or Coumadin use
- Recent hospitalization for asthma in the past 3 months
- Active smoking or more than 10 pack year smoking history
|Official title||Effects of Obesity on Airway Caliber and Airway Smooth Muscle Tone|
|Principal investigator||Emmanuelle Clerisme-Beaty, MD, MHS|
Call for more information